Avenue Therapeutics ATXI Estimates

OTC ATXI
$0.40 -0.03 (-6.98%)
At close: Oct 20, 2026 · 4:00 PM EDT
Analyst Estimates

Avenue Therapeutics, Inc. Annual Revenue Estimates

Periods 6
Next Period 2021
Consensus 27.22 M

Analysts expect Avenue Therapeutics, Inc. to report revenue of 27.22 M for 2021, against a range of 25.41 M to 29.03 M.

Metric 202120222023202420252028
Reported (Actual) --
High Estimate 29.03 M0.00
Low Estimate 25.41 M0.00
Consensus Estimate 27.22 M0.00
Analyst Estimates

Avenue Therapeutics, Inc. Earnings Per Share (EPS) Estimates

Periods 28
Next Period Q4 24
Consensus -0.54

Analysts expect Avenue Therapeutics, Inc. to report earnings per share of -0.54 for Q4 24, against a range of -0.58 to -0.50. The most recent reported quarter, Q2 26, came in at -0.21, a 101.9% miss against the 11.13 consensus.

Metric Q1 23Q2 23Q3 23Q4 23Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29
Reported (Actual) -102.75-39.004.5063.75-15.40-6.43-1.92--0.11-0.21-0.23--0.21-----
High Estimate -9.32-19.92-19.24-7.11-8.01-0.95-0.94-0.50-22.208.1611.962.59-26.8911.9518.143.52-31.6511.1819.13
Low Estimate -10.74-22.66-20.98-7.57-8.85-1.07-1.06-0.58-25.707.4810.222.39-32.6910.3115.323.24-36.5110.4015.81
Consensus Estimate -10.03-21.29-20.11-7.34-8.43-1.01-1.00-0.54-23.957.8211.092.49-29.7911.1316.733.38-34.0810.7917.47

Avenue Therapeutics, Inc. Estimates API

Pull Wall Street consensus for Avenue Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=ATXI&mode=revenue&api_key=YOUR_API_KEY